ACAD Financial Facts
Net loss: -71.61MCollaborative revenues: 5.27M
See Full Income Statement
See Full Balance Sheet
ACADIA Pharmaceuticals (ACAD) Earnings
|
Expand Research on ACAD
| Next EPS Date | 8/4/22 *Est. | EPS Growth Rate | -66.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +12.3% | Revenue Growth Rate | +8.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -9.9% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/4/22 |  |
Q122 | -$0.70 | -$0.60 | -$0.10 | $115.5M | $121.92M | = |  | | Details |
| 2/28/22 | |
Q421 | -$0.27 | -$0.24 | -$0.03 | $130.76M | $135.6M | = | | | Details |
| 11/8/21 | |
Q321 | -$0.09 | -$0.26 | +$0.17 | $131.6M | $127.75M | N/A | | | Details |
| 8/4/21 | |
Q221 | -$0.27 | -$0.31 | +$0.04 | $115.2M | $126.15M | = | | | Details |
| 5/5/21 | |
Q121 | -$0.42 | -$0.53 | +$0.11 | $106.6M | $111.63M | N/A | | | Details |
| 2/24/21 | |
Q420 | -$0.42 | -$0.47 | +$0.05 | $121.01M | $123.2M | N/A | | | Details |
| 11/4/20 | |
Q320 | -$0.54 | -$0.38 | -$0.16 | $120.6M | $118.82M | = | | | Details |
| 8/5/20 | |
Q220 | -$0.27 | -$0.44 | +$0.17 | $110M | $103.34M | = | | | Details |
